-
Care Partner Burden and Experiences With Schizophrenia: A National Canadian Survey
Sep 9, 2025, 16:22 PM -
Cost Trends for Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Management in Relapsed/Refractory Large B-cell Lymphoma (R/R LBCL) Treatment With Axicabtagene Ciloleucel (Axi-cel) in the US
Sep 9, 2025, 16:22 PM -
Optimizing Patient-Reported Outcomes in German HTA: Addressing Key Challenges and Methodological Requirements
Sep 9, 2025, 16:22 PM -
Pharmacist-Led Educational Intervention for Improving Pulmonary Tuberculosis Patients’ Treatment Adherence in Penang, Malaysia
Sep 9, 2025, 16:22 PM -
Development and Validation of a Case Identification Algorithm for Hand Trauma Patients Using Health Administrative Data and the Epidemiology of Hand Trauma in a Universal Healthcare System
Sep 9, 2025, 16:22 PM -
Pillcam COLON 2 for Investigation of the COLON Through Direct Visualization: A Systematic Review
Sep 9, 2025, 16:22 PM -
Comparative Cost Analysis of Bedaquiline and Linezolid-Based Regimens for MDR/XDR-TB in India: A Public vs. Private Sector Perspective
Sep 9, 2025, 16:22 PM -
Natural Language Processing for Identification of Negative Symptoms in Patients With and Without Cognitive Impairment Associated With Schizophrenia (CIAS)
Sep 9, 2025, 16:22 PM -
Country-Specific Adaptation of Health Economic Models With Generative AI: A Case Study in Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Modeling Comparator Arms With Similar Effectiveness: Implications for a Cost-Effectiveness Analysis of Compression Products for Venous Leg Ulcers
Sep 9, 2025, 16:22 PM -
Decoding Diagnosis Delay in Juvenile Idiopathic Arthritis (JIA)
Sep 9, 2025, 16:22 PM -
Clinical Characteristics Among Patients Screening for Hepatitis C Virus (HCV) and HCV Positivity Rates, 2020-2024: Analysis of US Real-World Data
Sep 9, 2025, 16:22 PM -
Real-World Insights Into Prostate Cancer Management Using Electronic Health Record-Derived Data From the UK
Sep 9, 2025, 16:22 PM -
Caregiver QALYs Deserve Better: Why It's Time for a Methodological Rethink
Sep 9, 2025, 16:22 PM -
A Methodological Framework for a Cost-Effectiveness Model to Evaluate Novel Interventions in Niemann-Pick Type C
Sep 9, 2025, 16:22 PM -
Solving the PICO Puzzle: Perspectives on Outcome Measures for Oncology Medicines in Assessments of the European Medicines Agency and Health Technology Assessment Organizations in Europe
Sep 9, 2025, 16:22 PM -
Improving the Conceptual Coverage of the 15-item Penn Parkinson’s Daily Activity Questionnaire (PDAQ-15) for Use in the Mild-to-Moderate Lewy Body Dementia Population
Sep 9, 2025, 16:22 PM -
The Development of the Private Healthcare Sector in Romania Between 2005 and 2023
Sep 9, 2025, 16:22 PM -
Bayesian Parametric Mixture Cure Survival Models With Delayed Treatment Effects and Application to Targeted Therapies in Advanced Ovarian Cancer
Sep 9, 2025, 16:22 PM -
Granulocyte-Colony Stimulating Factor (G-CSF) Reference and Biosimilar Products Using Real-World Data to Assess Data Variability Across Different Sources to Evaluate its Potential Utility in Regulatory Assessment: A Study by the Biologics and...
Sep 9, 2025, 16:22 PM